Saccharomyces boulardii in maintenance treatment of Crohn's disease (Q28144634)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: July 2000)

Language	Label	Description	Also known as
English	Saccharomyces boulardii in maintenance treatment of Crohn's disease	scientific article (publication date: July 2000)

Statements

scholarly article

0 references

Saccharomyces boulardii in maintenance treatment of Crohn's disease (English)

0 references

Crohn's disease

0 references

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

based on heuristic

inferred from title

author name string

M Guslandi

1

0 references

G Mezzi

2

0 references

M Sorghi

3

0 references

P A Testoni

4

0 references

language of work or name

0 references

publication date

July 2000

0 references

Digestive Diseases and Sciences

0 references

45

0 references

7

0 references

1462-4

0 references

Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotics in inflammatory bowel disease: new choices for an old disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial agents and Crohn's disease: do they have a therapeutic role?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ileal dysfunction and bacterial overgrowth in patients with Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of Saccharomyces boulardii against the cholera toxin in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ecological control of the gastrointestinal tract. The role of probiotic flora

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10961730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28144634&oldid=1866176855"